ARKF vs ARKG
ARK Fintech Innovation ETF vs ARK Genomic Revolution ETF
- • ARKF pays a higher dividend yield (0.10%).
Side-by-side metrics
| Metric | ARKF | ARKG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.75% |
Dividend yield Trailing 12-month yield. | 0.10% | 0.00% |
AUM Assets under management — bigger funds are typically more liquid. | $727M | $2.21B |
YTD return | -10.29% | 66.55% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.12 | 2.11 |
P/E ratio | 30.33 | — |
Last price | $42.90 | $47.17 |
Inception | — | — |
Issuer | ARK | ARK |
ARKF top holdings
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 9.06% |
| XYZ | Block Inc Class A | 8.15% |
| CRCL | Circle Internet Group Inc Ordinary Shares - Class A | 6.18% |
| COIN | Coinbase Global Inc Ordinary Shares - Class A | 5.30% |
| HOOD | Robinhood Markets Inc Class A | 4.78% |
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 4.62% |
| META | Meta Platforms Inc Class A | 4.55% |
| TOST | Toast Inc Class A | 4.20% |
| AMZN | Amazon.com Inc | 3.80% |
ARKG top holdings
| TWST | Twist Bioscience Corp | 8.75% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 8.73% |
| TEM | Tempus AI Inc Class A common stock | 8.36% |
| ABSI | Absci Corp | 5.56% |
| CRSP | CRISPR Therapeutics AG | 5.22% |
| GH | Guardant Health Inc | 4.88% |
| NTRA | Natera Inc | 4.71% |
| ILMN | Illumina Inc | 4.69% |
| LLY | Eli Lilly and Co | 3.92% |
| BEAM | Beam Therapeutics Inc | 3.69% |
About ARKF
ARKF (ARK Fintech Innovation ETF) is Fintech companies disrupting financial services. Managed by ARK, the fund carries $727M in assets under management, an expense ratio of 0.75%, a dividend yield of 0.10%. Its largest holding is Shopify Inc Registered Shs -A- Subord Vtg (SHOP), which represents 9.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 13.7%.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.